Package 72205-154-01

Brand: nelarabine

Generic: nelarabine
NDC Package

Package Facts

Identity

Package NDC 72205-154-01
Digits Only 7220515401
Product NDC 72205-154
Description

1 VIAL in 1 CARTON (72205-154-01) / 50 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2024-10-22
Brand nelarabine
Generic nelarabine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "d556a9e7-310b-41dc-99f8-a281fe7da3fe", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0372205154049", "0372205154018"], "unii": ["60158CV180"], "rxcui": ["603566"], "spl_set_id": ["d556a9e7-310b-41dc-99f8-a281fe7da3fe"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (72205-154-01)  / 50 mL in 1 VIAL", "package_ndc": "72205-154-01", "marketing_start_date": "20241022"}, {"sample": false, "description": "6 VIAL in 1 CARTON (72205-154-04)  / 50 mL in 1 VIAL", "package_ndc": "72205-154-04", "marketing_start_date": "20241022"}], "brand_name": "NELARABINE", "product_id": "72205-154_d556a9e7-310b-41dc-99f8-a281fe7da3fe", "dosage_form": "INJECTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "72205-154", "generic_name": "NELARABINE", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NELARABINE", "active_ingredients": [{"name": "NELARABINE", "strength": "5 mg/mL"}], "application_number": "ANDA216948", "marketing_category": "ANDA", "marketing_start_date": "20240913", "listing_expiration_date": "20261231"}